The ISO standards for Identification of Medicinal Products (IDMP) provide an internationally accepted framework to uniquely identify and describe medicinal products. Driven by regulatory requirements, the role of IDMP is to align the pharmaceutical industry on data standards for product and substance information. Realization of the full potential of IDMP depends on self-describing data to […]
Address – The Royal Society of Medicine, 1 Wimpole Street, London, W1G 0AE Data Driven Innovations – March 25 & 26, 2025 Join us at our European annual conference where new ideas are sparked and new initiatives are activated thanks to the power of collaboration. We are excited to be hosting this year’s event at […]
As a member of our community, take the opportunity to contribute to our annual global Lab of the Future survey 2024
Why your business will deliver more when you foster greater LGBTQIA+ inclusion in the workplace and how to get there This workshop is focused on LGBTQ+ inclusion in the workplace and includes a presentation on the importance of LGBTQ+ inclusion, highlighting key statistics, terms, and challenges faced by LGBTQ+ individuals, especially in life sciences. Participants […]
The project goal is to build an IDMP Ontology that enables deep, semantic interoperability based on FAIR principles to enhance and augment the existing IDMP standards.
This project will provide a core framework to create interoperability between FAIR data sets across the pharmaceutical industry.
New Idea ‘Regulatoria’ Round Table Discussion Problem Statement CMC Regulatory Specialists spend a lot of time copy-pasting and reformatting information from source documents into regulatory documents. Such Word/PDF processes result in unFAIR data. Besides they are commonly the root causes of slowness, waste/inefficiency, and compliance risk in regulatory dossier preparation, submission, and assessment. Given FDA […]
Survey of life sciences experts found 70% recognize potential for AI, but many are struggling to get started or implement it at scale due to challenges including data integrity and interoperability. London, 8 May 2024: The Pistoia Alliance, a global, not-for-profit alliance that advocates for greater collaboration in life sciences R&D, is calling for urgent […]
With the support from our sponsors and members, we have been able to create one of the largest conferences in the Pistoia Alliance’s history. Each sponsor has brought something new to the day, with the view to sharing their latest developments within the wider Pharma community.Amino was established in 2021 in response to the growing […]
Ontology will improve substance identification, cross-border prescriptions, regulatory process integration with manufacturers, supply-chain analytics, and pharmacovigilance Boston, US, January 24, 2024. The Pistoia Alliance, a global not-for-profit alliance that advocates for greater collaboration in life sciences R&D, has published its Identification of Medicinal Products (IDMP) Ontology 1.0 under an open-source license. The Pistoia Alliance plans […]
Linking pathology data with molecular and clinical data allows for a deeper understanding of disease, more accurate diagnosis, and ultimately better patient treatment. Pathology data needs to be structured in order to achieve this. The aim of this study was to make unstructured neuropathological data, located in the NeuroBioBank (NBB), follow FAIR (Findability, Accessibility, Interoperability, […]
A well-defined ontology that bridges between regional and functional perspectives on common substance-related data objects and global and scientifically objective representations is required. The goal of our project is to build an IDMP Ontology that enables deep, semantic interoperability based on FAIR principles to enhance and augment the existing ISO IDMP standards.
